Category: Licensing Deals

Insmed has been making waves in the pulmonary arterial hypertension (PAH) landscape. The company, known for its innovative treatments, is gradually

The Presidio of Monterey is taking a significant step forward in supporting its military community by incorporating neurofeedback therapy into its

Novo Nordisk, a powerhouse in the pharmaceutical industry, faces a pivotal moment as it seeks to reclaim its dominance in the weight loss market. Once

Johnson & Johnson (JNJ) has secured a significant partnership with Royalty Pharma, aimed at advancing research in autoimmune diseases. This collaboration,

Theravance Biopharma has made significant strides in its legal and commercial landscape with a recent settlement concerning YUPELRI, its inhalation

Material breach clauses play a critical role in licensing agreements, governing the rights and responsibilities of the parties involved. These clauses

Ligand Pharmaceuticals, a dynamic player in the biotech arena, has recently come under the spotlight due to a notable insider transaction. The Chief

Ligand Pharmaceuticals has recently garnered attention following an insider transaction that underscores the company’s robust performance and strategic

Johnson & Johnson (NYSE: JNJ) has long been a cornerstone of the pharmaceutical industry, celebrated for its vast diversification and resilience. With a

Antengene Corporation Limited has announced a significant global licensing agreement with UCB for its bispecific T cell engager (TCE), ATG 201, aimed at

Antengene and UCB have forged a significant global license agreement focusing on ATG 201, a bispecific T cell engager targeting CD19 and CD3. This

Tenaya Therapeutics has captured market attention with a significant surge in its stock price, following the announcement of a research collaboration